benzoxazoles has been researched along with Disease Models, Animal in 104 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (11.54) | 29.6817 |
| 2010's | 70 (67.31) | 24.3611 |
| 2020's | 22 (21.15) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, H; Kurihara, T; Lee, D; Miwa, Y; Negishi, K; Tomita, Y; Tsubota, K | 1 |
| Calvisi, DF; Chen, K; Chen, X; Evert, M; Li, B; Shang, R; Song, X; Xu, H; Zhang, Y; Zhong, S | 1 |
| Bello, D; Braillard, S; Caljon, G; Carvalho, S; Corpas-Lopez, V; Freund, Y; Gilbert, IH; Glossop, PA; Jacobs, RT; Lukac, I; Maes, L; Mowbray, CE; Nare, B; Pandi, B; Patterson, S; Speake, J; Van den Kerkhof, M; Wall, RJ; Whitlock, GA; Wyllie, S; Yardley, V; Zuccotto, F | 1 |
| Askari, K; Ghalebandi, S; Haghparast, A; Mousavi, Z; Zareie, F | 1 |
| Abe, H; Goto, R; Kamimura, H; Kamimura, K; Kimura, A; Morita, S; Oda, C; Ohkoshi-Yamada, M; Owaki, T; Sakai, N; Sakamaki, A; Shibata, O; Shinagawa-Kobayashi, Y; Terai, S; Yokoo, T | 1 |
| Asaji, M; Chang, J; Higo, T; Ide, S; Inui, H; Kamada, Y; Kanno, K; Koseki, M; Nishida, M; Ohama, T; Okada, T; Okuzaki, D; Ono, M; Saga, A; Saibara, T; Saito, S; Sakata, Y; Tanaka, K; Yamashita, S; Zhu, Y | 1 |
| Alani, R; Ali, D; Ardianto, C; Ayoub, R; Goh, KW; Jarrar, Q; Jilani, J; Moshawih, S | 1 |
| Chen, J; Ikeda, SI; Kunimi, H; Kurihara, T; Lee, D; Miwa, Y; Nakai, A; Negishi, K; Tomita, Y; Tsubota, K | 1 |
| Anzai, N; Endou, H; Fujita, T; Hayashi, K; Hiroi, T; Iwata, Y; Jutabha, P; Kaminuma, O; Kanai, Y; Kurasawa, K; Matsuoka, K; Nishimura, T; Okayasu, I; Ouchi, M; Owada, T; Saeki, M; Sugiura, K | 1 |
| Abels, C; Ahrens, K; Marsella, R; Massre, D; Sanford, R; Soeberdt, M; Trujillo, A | 1 |
| Bucala, R; Chen, D; Fu, Q; Huang, H; Leng, L; Li, J; Lu, L; Pu, J; Ye, S; Yuan, A | 1 |
| Costagliola, S; De Deken, X; Dumont, JE; Gillotay, P; Giusti, N; Opitz, R; Trubiroha, A | 1 |
| Ha, EH; Hu, Q; Li, H; Li, Z; Pang, J; Tian, S; Wang, W; Zhou, M | 1 |
| Endou, H; Fujita, T; Hayashi, K; Kaminuma, O; Nishimura, T; Ogata, S; Saeki, M; Yamasaki, N | 1 |
| Haghparast, A; Kashfi, K; Manaheji, H; Salehi, S | 1 |
| Abrari, K; Elahdadi Salmani, M; Lashkarbolouki, T; Nasiri, M; Salehabadi, S | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Aburatani, H; Anai, M; Asahiyama, M; Fruchart, JC; Kamiya, W; Kodama, T; Matsumura, Y; Murakami, K; Osawa, T; Sakai, J; Sasaki, Y; Tanaka, T; Yamamoto, S | 1 |
| Gholami, M; Joghataei, MT; Komaki, A; Kourosh-Arami, M; Lavaie, M; Najafi, Z | 1 |
| Jiang, X; Kurihara, T; Lee, D; Miwa, Y; Ohta, M; Tomita, Y; Tsubota, K | 1 |
| Campbell, EJ; Hill, MK; Jin, S; Lawrence, AJ; Maddern, XJ; Pang, TY | 1 |
| Ban, SR; Gao, XH; Ge, R; Li, QS; Luo, JR; Shi, XY; Tang, L; Zhao, B | 1 |
| Arizono, I; Fujita, N; Kitaoka, Y; Sase, K; Takagi, H; Tsukahara, C | 1 |
| Gaikwad, NJ; Gaikwad, SS; Patil, ML | 1 |
| Bernhart, E; Joshi, L; Köfeler, HC; Plastira, I; Reicher, H; Sattler, W; Triebl, A | 1 |
| Han, SI; Matsuzaka, T; Nakagawa, Y; Satoh, A; Sekiya, M; Shimano, H; Takei, K; Wang, Y | 1 |
| Cato, MJ; Clements, MK; Daley, CJ; Filzen, T; Finger, EN; Gregan, Y; Henze, DA; Houghton, AK; Jovanovska, A; Kelly, MJ; Klein, R; Kraus, RL; Layton, ME; Lehman, HDGF; Li, Y; Liang, A; Majercak, JM; Mulhearn, JJ; Panigel, J; Pero, JE; Rossi, MA; Urban, MO; Wang, J; Wang, YH; Wolkenberg, SE | 1 |
| Hirao, K; Ibrahim, NF; Kato, T; Morikawa, S; Shirai, N; Sogabe, T; Taguchi, H; Tooyama, I; Yanagisawa, D | 1 |
| Conn, PJ; Fisher, NM; Gogliotti, RG; Niswender, CM; Stansley, BJ; Vermudez, SAD | 1 |
| Haghparast, A; Karimi-Haghighi, S; Mousavi, Z; Sahafzadeh, M | 1 |
| Chen, Z; Ge, Y; Guo, Y; Li, J; Li, Y; Shang, C; Song, D; Song, R; Wu, N; Zhao, T | 1 |
| Kaur, A; Pathak, DP; Sharma, V; Wakode, S | 1 |
| Dou, H; Hou, Y; Li, D; Li, X; Ren, J; Shi, G; Wang, T | 1 |
| Dong, T; Fukunaga, K; Ibata, T; Imachi, H; Iwama, H; Kobayashi, T; Lyu, J; Murao, K; Sato, S; Yonezaki, K; Yoshimoto, T; Zhang, G | 1 |
| Altmann, KH; Charles, RP; Dettmer, MS; Gertsch, J; Graff, J; Häfliger, P; Rubin, M; Stooss, A | 1 |
| Abbasnejad, M; Esmaeili-Mahani, S; Kooshki, R; Raoof, M | 2 |
| Bailey, A; Bigi, R; Caro-Vegas, C; Damania, B; Dittmer, DP | 1 |
| Li, NS; Li, T; Liu, B; Luo, XJ; Peng, J; Peng, JJ; Song, FL; Wang, EL; Yang, JF | 1 |
| Jeon, J; Kim, M; Kim, YH; Lee, KO; Min, KH; Song, J; Suh, KH | 1 |
| Jung, HK; Jung, SA; Kim, SE; Lee, JS; Park, HY; Shim, KN; Song, EM; Yoo, K | 1 |
| Alzoubi, KH; Jilani, JA; Shomaf, M | 1 |
| Cornish, JL; Staples, LG | 1 |
| Martin-Fardon, R; Weiss, F | 1 |
| Mediavilla, C; Risco, S | 1 |
| Adidharma, W; Deats, SP; Lonstein, JS; Yan, L | 1 |
| Baron, T; Billard, T; Bouillot, C; Chauveau, F; Lancelot, S; Levigoureux, E; Verchere, J; Verdurand, M; Zimmer, L | 1 |
| Cornish, JL; Staples, LG; Vanderhaven, MW | 1 |
| de Stanchina, E; Patwardhan, PP; Schwartz, GK; Slotkin, EK; Tap, WD; Vasudeva, SD | 1 |
| Kumei, S; Miyagishi, S; Nozu, T; Ohhira, M; Okumura, T; Takakusaki, K | 1 |
| Chen, MB; Cui, JF; Li, C; Liu, CY; Liu, F; Lu, PH; Zhang, QD; Zou, J | 1 |
| Cui, Y; Guo, SJ; Huang, ZZ; Jiang, JX; Liu, H; Xin, WJ; Zhang, XQ | 1 |
| Blat, S; Blat, Y | 1 |
| Bernstein, DL; Brodnik, ZD; España, RA; Prince, CD | 1 |
| Fujinaga, M; Hatori, A; Higuchi, M; Ji, B; Kumata, K; Luo, R; Maeda, J; Shimoda, Y; Tiwari, AK; Wang, F; Xie, L; Yamasaki, T; Yui, J; Zhang, MR; Zhang, Y | 1 |
| Davis, C; Gallo, RC; Gartenhaus, RB; Heredia, A; Le, N; Medina-Moreno, S; Redfield, RR; Sausville, E; Zapata, JC | 1 |
| Liu, B; Lou, Z; Luo, XJ; Ma, QL; Peng, J; Peng, JJ; Ren, KD; Ren, X; Tan, B; Yang, J; Yang, ZB | 1 |
| Li, DP; Yuan, F; Zhang, Y; Zhou, JJ | 1 |
| Bosquesi, PL; Chung, MC; Marcondes, S; Melchior, AC; Pavan, AR; Pires, ME; Rosseto, LA; Santos, JL | 1 |
| Dunn-Meynell, A; Levin, BE; Otlivanchik, O; Sanders, NM | 1 |
| Abt, E; Dubinett, SM; Fishbein, MC; Magyar, C; McMickle, R; Momcilovic, M; Seki, A; Shackelford, DB; Simko, SA; Stout, DB; Walser, TC | 1 |
| Ancellin, N; Baily, JE; Beaufils, B; Bénéton, V; Binnie, M; Garden, OJ; Haslam, C; Holmes, DS; Homer, NZ; Howie, SE; Hughes, J; Hutchinson, JP; Iredale, JP; Liddle, J; McBride, A; Mirguet, O; Mole, DJ; Mowat, CG; Rowland, P; Sharp, MG; Trottet, L; Uings, I; Walker, A; Webster, SP; Wilkinson, M; Wilson, K; Zheng, X | 1 |
| Ayoobi, F; Fatemi, I; Motevalian, M; Roohbakhsh, A; Sanati, MH; Shamsizadeh, A; Taghipour, Z | 1 |
| Campbell, AD; Eitzman, DT; Guo, C; Harro, D; Tran, J; Wang, H; Wang, J | 1 |
| Alvarez, R; Bettencourt, BR; Borland, TD; Butler, JS; Chan, A; Chen, Q; Costelha, S; Fishman, S; Fitzgerald, K; Foster, DJ; Gonçalves, P; Manoharan, M; Meyers, RE; Milstein, S; Nochur, SV; Qin, J; Rajeev, KG; Sah, DW; Saraiva, MJ; Willoughby, JL; Zimmermann, TS | 1 |
| Daldrup, T; Derksen, A; Hartung, HP; Kieseier, BC; Meyer Zu Hörste, G; Steiner, I; Szepanowski, F | 1 |
| Antonioli, L; Bernardini, N; Blandini, F; Blandizzi, C; Cerri, S; Colucci, R; Cseri, K; Fornai, M; Haskó, G; Ippolito, C; Levandis, G; Pellegrini, C; Segnani, C; Tirotta, E | 1 |
| Esmaeili, MH; Ezzatpanah, S; Haghparast, A; Reisi, Z | 1 |
| Abbasnejad, M; Bahaaddini, M; Esmaeili-Mahani, S; Khatamsaz, S; Raoof, M | 1 |
| Aston-Jones, G; James, MH; Kilroy, EA; Moorman, DE | 1 |
| Azizi, H; Hooshmand, B; Javan, M; Semnanian, S | 1 |
| Aidinis, V; Dalekos, GN; Dimitriadis, A; Evangelou, K; Foka, P; Georgopoulou, U; Gorgoulis, VG; Harokopos, V; Kaffe, E; Katsifa, A; Moulas, AN; Ninou, I; Xylourgidis, N; Zannikou, M | 1 |
| Choo, HP; Hwang, ES; Jang, EJ; Jeong, H; Jeong, MG; Kim, D; Oh, S; Oh, YJ; Won, HY | 1 |
| Fujita, K; Honda, Y; Imajo, K; Kessoku, T; Nagashima, Y; Nakajima, A; Ogawa, Y; Saito, S; Takizawa, T; Tomeno, W; Yoneda, M | 1 |
| Bradshaw, E; Broom, DC; Buck, ME; Coombs, S; Cortright, DN; Ford, KK; Krause, JE; Matchett, M; Matson, DJ; Meade, R; Ochoa, R; Sun, SH; Wustrow, DJ; Yu, W; Yuan, J | 1 |
| Chai, KY; Guan, LP; Jia, JH; Quan, ZS; Wei, CX | 1 |
| Cannella, N; Ciccocioppo, R; Economidou, D; Heilig, M; Kallupi, M; Massi, M; Stopponi, S | 1 |
| Di Paolo, T; Grégoire, L; Lévesque, D; Morissette, M; Ouattara, B; Rouillard, C; Samadi, P; Tamim, MK | 1 |
| Aston-Jones, G; Smith, RJ; Tahsili-Fahadan, P | 1 |
| Anderson, LB; Braun, PD; Fairbanks, CA; Honda, CN; Kitto, KF; Riedl, MS; Roiko, SA; Vulchanova, L | 1 |
| Bélanger, N; Di Paolo, T; Hadj Tahar, A; Morissette, M; Samadi, P | 1 |
| Chen, MC; Liu, YP; Sun, SH; Tzeng, SF; Yang, CS | 1 |
| De Carolis, L; Milella, MS; Nativio, P; Nencini, P; Passarelli, F; Scaccianoce, S; Schepisi, C | 1 |
| Jackson, MJ; Jenner, P; Johnston, LC; McCreary, AC; Rose, S | 1 |
| Jackson, MJ; Jenner, P; McCreary, AC; Rose, S; Tayarani-Binazir, K | 1 |
| Chen, X; Kirouac, GJ; Li, S; Li, Y; Qi, K; Sui, N; Wang, H | 1 |
| Birnbaum, SG; Elmquist, JK; Lutter, M; Marcus, JN; Mochizuki, T; Nestler, EJ; Pettersen, A; Scammell, TE; Scott, MM | 1 |
| Kubin, L; Stettner, GM; Volgin, DV | 1 |
| Barrett, MP; Brun, R; Don, R; Jacobs, RT; Wang, MZ | 1 |
| Bacchi, CJ; Chen, D; Don, R; Freund, Y; Gaukel, EG; Jacobs, RT; Jenks, M; Nare, B; Noe, RA; Orr, MD; Perales, JB; Plattner, JJ; Sligar, JM; Wring, SA; Yarlett, N; Zhang, YK | 1 |
| Chiou, LC; Fu, SY; Ho, YC; Lee, HJ; Liao, HT; Liao, YY; Mackie, K; Teng, SF; Tung, LW | 1 |
| Austin, JS; Beggs, S; Costigan, M; Diatchenko, L; Dorfman, R; Gershon, E; Herbert, TA; John, SL; Jordan, J; Livneh, J; Maixner, W; Mogil, JS; Peltz, G; Ritchie, J; Salter, MW; Seltzer, Z; Slade, GD; Smith, SB; Sorge, RE; Tan, K; Tichauer, D; Trang, T; Vander Meulen, H; Woolf, CJ; Yarkoni-Abitbul, M; Zaykin, DV; Zheng, M | 1 |
| Fitz, SD; Johnson, PL; Lightman, SL; Lowry, CA; Samuels, BC; Shekhar, A | 1 |
| Dehpour, AR; Esmaeili, B; Ghaffarpour, M; Javadi-Paydar, M; Mirbaha, H; Motiei-Langroudi, R; Tabaeizadeh, M; Tahsili-Fahadan, P | 1 |
| Fruman, DA; Janes, MR; Jessen, KA; Li, LS; Lilly, MB; Limon, JJ; Liu, Y; Mallya, S; Martin, MB; Ren, P; Rommel, C; Sender, LS; Shieh, MP; Vu, C | 1 |
| Guo, Y; Kwiatkowski, DJ | 1 |
| Imada, T; Kobayashi, F; Komorita, N; Kondo, T; Miyazaki, M; Naito, K; Nakamura, N; Yoshikawa, T | 1 |
| Hirota, K; Kudo, M; Kudo, T; Kushikata, T; Matsuki, A; Smart, D | 1 |
| Bédard, PJ; Bélanger, N; Darré, A; Grégoire, L; Hadj Tahar, A; Meltzer, L | 1 |
| Akatsu, H; Arai, H; Kudo, Y; Okamura, N; Sasaki, H; Sawada, T; Shimadzu, H; Shiomitsu, T; Staufenbiel, M; Suemoto, T; Suzuki, M; Yamamoto, T; Yanai, K | 1 |
| Deng, BS; Fukuda, Y; Kuwaki, T; Nakamura, A; Yanagisawa, M; Zhang, W | 1 |
| Bédard, PJ; Belanger, N; Calon, F; Di Paolo, T; Dridi, M; Hadj Tahar, A; Meltzer, LT; Morissette, M; Samadi, P | 1 |
| Arredondo, C; Basombrío, MA; Boiani, L; Boiani, M; Cerecetto, H; Davies, C; Gerpe, A; González, M; Merlino, A; Pacheco, JP; Porcal, W | 1 |
| Arch, JR; Cawthorne, MA; Chapman, H; Clapham, JC; Haynes, AC; Moore, GB; Tadayyon, M; Taylor, C | 1 |
4 review(s) available for benzoxazoles and Disease Models, Animal
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
[Orexin: clinical and therapeutic implications].
Topics: Animals; Arousal; Azepines; Benzoxazoles; Disease Models, Animal; Drug Evaluation, Preclinical; Feeding and Eating Disorders; Feeding Behavior; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mice, Knockout; Mice, Transgenic; Motor Activity; Naphthyridines; Narcolepsy; Neuropeptides; Obesity; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Sleep Disorders, Circadian Rhythm; Sleep Disorders, Intrinsic; Substance-Related Disorders; Triazoles; Urea | 2014 |
Drug Discovery of Therapies for Duchenne Muscular Dystrophy.
Topics: Animals; Antioxidants; Benzoxazoles; Calcium; Disease Models, Animal; Drug Discovery; Dystrophin; Gene Expression; Humans; Muscular Dystrophy, Duchenne; Oxadiazoles | 2015 |
Development of novel drugs for human African trypanosomiasis.
Topics: Animals; Antiprotozoal Agents; Benzoxazoles; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Haplorhini; Humans; Mice; Neglected Diseases; Nitroimidazoles; Trypanosoma brucei brucei; Trypanosomiasis, African | 2011 |
1 trial(s) available for benzoxazoles and Disease Models, Animal
100 other study(ies) available for benzoxazoles and Disease Models, Animal
| Article | Year |
|---|---|
Pemafibrate Prevents Retinal Dysfunction in a Mouse Model of Unilateral Common Carotid Artery Occlusion.
Topics: Animals; Arterial Occlusive Diseases; Benzoxazoles; Butyrates; Carotid Artery, Common; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Retinal Diseases | 2021 |
Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma.
Topics: Anilides; Animals; Benzoxazoles; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Female; Humans; Liver Neoplasms; MAP Kinase Signaling System; Mice; Molecular Targeted Therapy; Mutation; Piperazines; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; PTEN Phosphohydrolase; Pyridines; Pyrimidines; Thiazoles; Treatment Outcome; Tumor Burden | 2021 |
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Benzoxazoles; Boron Compounds; Cricetinae; Disease Models, Animal; Dogs; Humans; Leishmaniasis, Visceral; Mice; Pyridines; Structure-Activity Relationship | 2021 |
Orexin receptors in the CA1 region of hippocampus modulate the stress-induced antinociceptive responses in an animal model of persistent inflammatory pain.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoxazoles; CA1 Region, Hippocampal; Cyclophosphamide; Disease Models, Animal; Doxorubicin; Etoposide; Inflammation; Isoquinolines; Male; Microinjections; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Pain; Pain Measurement; Prednisone; Pyridines; Rats, Wistar; Stress, Psychological; Urea; Vincristine | 2022 |
Effects of a novel selective PPARα modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis model.
Topics: Animal Fins; Animals; Animals, Genetically Modified; Benzhydryl Compounds; Benzoxazoles; Butyrates; Diet, High-Fat; Disease Models, Animal; Exome Sequencing; Gene Ontology; Glucosides; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Non-alcoholic Fatty Liver Disease; Oryzias; PPAR alpha; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Glucose Transporter 2 Inhibitors; Transcriptome | 2022 |
Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy.
Topics: Animals; Benzoxazoles; Butyrates; Cardiomyopathies; Diet, High-Fat; Dietary Carbohydrates; Disease Models, Animal; Gene Expression; Inflammasomes; Liver; Male; Mice, Inbred C57BL; Myocardium; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease | 2022 |
Synthesis and In-Vivo Evaluation of Benzoxazole Derivatives as Promising Anti-Psoriatic Drugs for Clinical Use.
Topics: Animals; Benzoxazoles; Disease Models, Animal; Imiquimod; Mice; Mice, Inbred CBA; Pharmaceutical Preparations; Psoriasis; Skin | 2022 |
Retinal degeneration induced in a mouse model of ischemia-reperfusion injury and its management by pemafibrate treatment.
Topics: Animals; Benzoxazoles; Butyrates; Disease Models, Animal; Ischemia; Mice; PPAR alpha; Reperfusion Injury; Retinal Degeneration | 2022 |
LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation.
Topics: Amino Acid Transport System y+L; Animals; Benzoxazoles; CD4-Positive T-Lymphocytes; Cells, Cultured; Dermatitis, Atopic; Disease Models, Animal; Humans; Large Neutral Amino Acid-Transporter 1; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Knockout; Signal Transduction; Th2 Cells; Treatment Outcome; Tyrosine | 2020 |
Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles.
Topics: Administration, Topical; Animals; Benzoxazoles; Cross-Over Studies; Dermatitis, Atopic; Disease Models, Animal; Dogs; Double-Blind Method; Endocannabinoids; Female; Gels; Male; Membrane Transport Modulators; Membrane Transport Proteins; Pruritus; Pyroglyphidae; Severity of Illness Index; Skin; Treatment Outcome | 2019 |
The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.
Topics: Adult; Animals; Benzoxazoles; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Disease Models, Animal; Female; Fibrosis; Humans; Intramolecular Oxidoreductases; Lupus Erythematosus, Systemic; Macrophage Migration-Inhibitory Factors; Male; Mice, Inbred C57BL; Middle Aged; Mitogen-Activated Protein Kinases; Myocytes, Smooth Muscle; Pulmonary Arterial Hypertension; Pulmonary Artery | 2019 |
Inhibition of the thyroid hormonogenic H
Topics: Animals; Benzoxazoles; Disease Models, Animal; Dual Oxidases; Gene Expression Regulation; Gene Regulatory Networks; Goiter; Hydrogen Peroxide; Mutation; NADPH Oxidases; Thyroid Hormones; Triazoles; Zebrafish; Zebrafish Proteins | 2020 |
Development of novel NLRP3-XOD dual inhibitors for the treatment of gout.
Topics: Animals; Benzimidazoles; Benzoxazoles; Cell Line; Disease Models, Animal; Gout; Humans; Hyperuricemia; Interleukin-1beta; Liver; Mice; Monocytes; NLR Family, Pyrin Domain-Containing 3 Protein; Oxonic Acid; Rats; Structure-Activity Relationship; Synovial Membrane; Uric Acid; Xanthine Oxidase | 2020 |
L-type amino acid transporter 1 (LAT1)-specific inhibitor is effective against T cell-mediated nasal hyperresponsiveness.
Topics: Activating Transcription Factor 4; Animals; Benzoxazoles; Cytokines; Disease Models, Animal; gamma-Glutamylcyclotransferase; Large Neutral Amino Acid-Transporter 1; Lymphocyte Activation; Mice; Rhinitis, Allergic; Signal Transduction; T-Lymphocytes; Tyrosine | 2020 |
Chemical stimulation of the lateral hypothalamus induces antiallodynic and anti-thermal hyperalgesic effects in animal model of neuropathic pain: Involvement of orexin receptors in the spinal cord.
Topics: Animals; Benzoxazoles; Carbachol; Disease Models, Animal; Dose-Response Relationship, Drug; Hot Temperature; Hyperalgesia; Hypothalamic Area, Lateral; Isoquinolines; Naphthyridines; Neuralgia; Orexin Receptor Antagonists; Orexin Receptors; Pain Management; Pain Threshold; Pyridines; Rats; Rats, Wistar; Spinal Cord; Urea | 2020 |
Investigating the role of the amygdala orexin receptor 1 in memory acquisition and extinction in a rat model of PTSD.
Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Benzoxazoles; Disease Models, Animal; Elevated Plus Maze Test; Extinction, Psychological; Fear; Freezing Reaction, Cataleptic; Hypothalamus; Memory; Naphthyridines; Open Field Test; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Rats; RNA, Messenger; Stress Disorders, Post-Traumatic; Urea | 2020 |
Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content.
Topics: Animals; Benzoxazoles; Butyrates; Disease Models, Animal; Endothelial Cells; Hepatocytes; Humans; Lipid Metabolism; Liver; Macrophages; Mice; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; PPAR alpha; Triglycerides; Vascular Cell Adhesion Molecule-1 | 2020 |
Persistent effects of the orexin-1 receptor antagonist SB-334867 on naloxone precipitated morphine withdrawal symptoms and nociceptive behaviors in morphine dependent rats.
Topics: Animals; Behavior, Animal; Benzoxazoles; Disease Models, Animal; Morphine; Morphine Dependence; Naloxone; Naphthyridines; Narcotic Antagonists; Narcotics; Nociceptive Pain; Orexin Receptor Antagonists; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Urea | 2022 |
Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy.
Topics: Animals; Benzoxazoles; Blood Glucose; Body Weight; Butyrates; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Electroretinography; Fibroblast Growth Factors; Gene Expression Regulation; Lipid Metabolism; Liver Function Tests; Male; Mice; Retina; Streptozocin; Synaptophysin; Treatment Outcome | 2020 |
Orexin-1 receptor signaling within the lateral hypothalamus, but not bed nucleus of the stria terminalis, mediates context-induced relapse to alcohol seeking.
Topics: Alcohol Drinking; Alcoholism; Animals; Behavior, Addictive; Behavior, Animal; Benzoxazoles; Conditioning, Operant; Disease Models, Animal; Lateral Thalamic Nuclei; Male; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Punishment; Rats; Septal Nuclei; Signal Transduction; Urea | 2020 |
Design and synthesis of new disubstituted benzoxazolone derivatives that act as iNOS inhibitors with potent anti-inflammatory activity against LPS-induced acute lung injury (ALI).
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Benzoxazoles; Disease Models, Animal; Drug Design; Edema; Gene Expression Regulation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Lung; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxidase; RAW 264.7 Cells | 2020 |
Pemafibrate prevents retinal neuronal cell death in NMDA-induced excitotoxicity via inhibition of p-c-Jun expression.
Topics: Animals; Benzoxazoles; Butyrates; Cell Death; Diabetic Retinopathy; Disease Models, Animal; JNK Mitogen-Activated Protein Kinases; Male; N-Methylaspartate; Neurons; Phosphorylation; PPAR alpha; Rats; Retina; Retinal Ganglion Cells | 2021 |
Anti-nociceptive and Anti-inflammatory Activity of Synthesized Novel Benzoxazole Derivatives.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Benzoxazoles; Carrageenan; Disease Models, Animal; Edema; Male; Mice; Nociception; Pain; Plant Extracts | 2021 |
Inhibition of Autotaxin and Lysophosphatidic Acid Receptor 5 Attenuates Neuroinflammation in LPS-Activated BV-2 Microglia and a Mouse Endotoxemia Model.
Topics: Animals; Benzoxazoles; Brain; Cell Line; Disease Models, Animal; Endotoxemia; Inflammation; Isoquinolines; Lipopolysaccharides; Mice; Microglia; Phosphoric Diester Hydrolases; Piperazines; Piperidines; Receptors, Lysophosphatidic Acid | 2021 |
Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice.
Topics: Animals; Atherosclerosis; Benzoxazoles; Butyrates; Cholesterol; Disease Models, Animal; Fatty Acids; Gene Expression; Gene Knockout Techniques; Hyperlipidemias; Intestinal Absorption; Intestine, Small; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Molecular Targeted Therapy; Oxidation-Reduction; PPAR alpha; Receptors, LDL | 2017 |
Benzoxazolinone aryl sulfonamides as potent, selective Na
Topics: Administration, Oral; Analgesics; Animals; Benzoxazoles; Biological Availability; Disease Models, Animal; Dose-Response Relationship, Drug; Formaldehyde; Humans; Mice; Molecular Structure; Myocytes, Smooth Muscle; NAV1.7 Voltage-Gated Sodium Channel; Pain; Rats; Structure-Activity Relationship; Sulfonamides | 2017 |
Fluorine-19 magnetic resonance imaging probe for the detection of tau pathology in female rTg4510 mice.
Topics: Aged; Alzheimer Disease; Animals; Benzoxazoles; Brain; Butadienes; Disease Models, Animal; Female; Fluorine; Fluorine-19 Magnetic Resonance Imaging; Humans; Male; Mice; Mice, Transgenic; Neurofibrillary Tangles; tau Proteins; Tauopathies | 2018 |
Genetic Reduction or Negative Modulation of mGlu
Topics: Allosteric Regulation; Animals; Anxiety; Benzoxazoles; Disease Models, Animal; Excitatory Amino Acid Agonists; Fear; Learning; Mental Retardation, X-Linked; Mice; Phenotype; Phosphinic Acids; Receptors, Metabotropic Glutamate | 2018 |
Role of the orexin receptors within the nucleus accumbens in the drug priming-induced reinstatement of morphine seeking in the food deprived rats.
Topics: Animals; Benzoxazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Food Deprivation; Isoquinolines; Male; Morphine; Morphine Dependence; Naphthyridines; Narcotics; Nucleus Accumbens; Orexin Receptor Antagonists; Orexin Receptors; Pyridines; Rats, Wistar; Urea | 2018 |
Role of dopamine D3 receptor in alleviating behavioural deficits in animal models of post-traumatic stress disorder.
Topics: Animals; Anxiety; Benzoxazoles; Disease Models, Animal; Dopamine Antagonists; Electroshock; Freezing Reaction, Cataleptic; Male; Mice, Inbred C57BL; Mice, Knockout; Piperazines; Rats, Sprague-Dawley; Receptors, Dopamine D3; Stress Disorders, Post-Traumatic | 2018 |
Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Benzamides; Benzoxazoles; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Design; Edema; Female; Humans; Ibuprofen; Inhibitory Concentration 50; Molecular Docking Simulation; Rats; Rats, Wistar; Structure-Activity Relationship | 2018 |
mTOR inhibitor INK128 attenuates dextran sodium sulfate-induced colitis by promotion of MDSCs on Treg cell expansion.
Topics: Animals; Benzoxazoles; Cell Communication; Cell Proliferation; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Female; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred C57BL; Myeloid-Derived Suppressor Cells; Protein Kinase Inhibitors; Pyrimidines; RAW 264.7 Cells; Signal Transduction; T-Lymphocytes, Regulatory; Th1 Cells; TOR Serine-Threonine Kinases | 2019 |
Selective peroxisome proliferator-activated receptor-α modulator K-877 regulates the expression of ATP-binding cassette transporter A1 in pancreatic beta cells.
Topics: Animals; ATP Binding Cassette Transporter 1; Benzoxazoles; Butyrates; Cell Line, Tumor; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Dyslipidemias; Glucose; Glucose Intolerance; Humans; Hypolipidemic Agents; Insulin; Insulin-Secreting Cells; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Oxazoles; PPAR alpha; Promoter Regions, Genetic; Rats; RNA, Messenger; Tyrosine | 2018 |
The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model.
Topics: Animals; Animals, Genetically Modified; Apoptosis; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Signal Transduction; Thyroid Carcinoma, Anaplastic; Thyroid Gland; Tyrosine | 2018 |
The effect of CA1 administration of orexin-A on hippocampal expression of COX-2 and BDNF in a rat model of orofacial pain.
Topics: Animals; Benzoxazoles; Brain-Derived Neurotrophic Factor; Capsaicin; Cyclooxygenase 2; Disease Models, Animal; Facial Pain; Hippocampus; Male; Naphthyridines; Neurons; Orexin Receptors; Orexins; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Urea | 2018 |
Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Benzoxazoles; Cell Cycle Checkpoints; Cell Line, Tumor; Disease Models, Animal; Enzyme Inhibitors; Heterografts; Humans; Inhibitory Concentration 50; Lymphoma, Primary Effusion; Mice; Neoplasm Transplantation; Pyrimidines; Sirolimus; TOR Serine-Threonine Kinases; Treatment Outcome | 2019 |
Magnesium Lithospermate B Derived from Salvia miltiorrhiza Ameliorates Right Ventricle Remodeling in Pulmonary Hypertensive Rats via Inhibition of NOX/VPO1 Pathway.
Topics: Animals; Atrial Natriuretic Factor; Benzoxazoles; Cell Hypoxia; Cell Line; Disease Models, Animal; Drugs, Chinese Herbal; Hemeproteins; Hypertension, Pulmonary; Male; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Natriuretic Peptide, Brain; Peroxidases; Rats, Sprague-Dawley; Salvia miltiorrhiza; Triazoles; Ventricular Remodeling | 2019 |
Synthesis of proline analogues as potent and selective cathepsin S inhibitors.
Topics: Animals; Arthritis; Benzoxazoles; Cathepsin B; Cathepsin K; Cathepsins; Collagen; Disease Models, Animal; Dogs; Enzyme Inhibitors; Half-Life; Humans; Mice; Mice, Inbred ICR; Microsomes; Proline; Protein Binding; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship | 2013 |
[Benzoxazole derivative B-98 ameliorates dextran sulfate sodium-induced acute murine colitis and the change of T cell profiles in acute murine colitis model].
Topics: Acute Disease; Animals; Arachidonate 5-Lipoxygenase; Benzoxazoles; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Forkhead Transcription Factors; Injections, Intraperitoneal; Interleukin-6; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred C57BL; Severity of Illness Index; T-Lymphocytes | 2013 |
Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitis.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoxazoles; Colitis, Ulcerative; Disease Models, Animal; Female; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mesalamine; Prodrugs; Rats; Rats, Wistar; Salicylates; Spectrophotometry, Infrared; Trinitrobenzenesulfonic Acid | 2013 |
The orexin-1 receptor antagonist SB-334867 attenuates anxiety in rats exposed to cat odor but not the elevated plus maze: an investigation of Trial 1 and Trial 2 effects.
Topics: Animals; Anxiety; Avoidance Learning; Behavior, Animal; Benzoxazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Maze Learning; Naphthyridines; Odorants; Orexin Receptor Antagonists; Rats; Rats, Wistar; Recognition, Psychology; Stress, Psychological; Urea | 2014 |
Blockade of hypocretin receptor-1 preferentially prevents cocaine seeking: comparison with natural reward seeking.
Topics: Analysis of Variance; Anesthetics, Local; Animals; Benzoxazoles; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Male; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Rats; Rats, Wistar; Reward; Self Administration; Sweetening Agents; Urea | 2014 |
Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency.
Topics: Animals; Anxiety; Behavior, Animal; Benzoxazoles; Circadian Rhythm; Depression; Disease Models, Animal; Intracellular Signaling Peptides and Proteins; Light; Male; Motor Activity; Naphthyridines; Neuropeptides; Orexins; Photoperiod; Phototherapy; Rats; Seasonal Affective Disorder; Signal Transduction; Urea | 2014 |
Binding of the PET radiotracer [¹⁸F]BF227 does not reflect the presence of alpha-synuclein aggregates in transgenic mice.
Topics: alpha-Synuclein; Animals; Benzoxazoles; Brain Stem; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Positron-Emission Tomography; Radioligand Assay; Tauopathies; Thalamus; Thiazoles | 2014 |
The orexin-1 receptor antagonist SB-334867 decreases anxiety-like behavior and c-Fos expression in the hypothalamus of rats exposed to cat odor.
Topics: Analysis of Variance; Animals; Anxiety; Benzoxazoles; Cats; Disease Models, Animal; Gene Expression Regulation; Hypothalamus; Male; Naphthyridines; Odorants; Proto-Oncogene Proteins c-fos; Random Allocation; Rats; Rats, Wistar; Receptors, Neuropeptide; Urea | 2015 |
MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Down-Regulation; Female; Humans; Inhibitory Concentration 50; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice, Nude; Multiprotein Complexes; Osteosarcoma; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Sarcoma; Sirolimus; Substrate Specificity; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2015 |
Antinociceptive action against colonic distension by brain orexin in conscious rats.
Topics: Analgesics; Animals; Benzoxazoles; Brain; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Electrodes, Implanted; Intracellular Signaling Peptides and Proteins; Male; Morphine; Naphthyridines; Neuropeptides; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Pain Threshold; Physical Stimulation; Rats, Sprague-Dawley; Urea; Visceral Pain | 2015 |
The preclinical evaluation of the dual mTORC1/2 inhibitor INK-128 as a potential anti-colorectal cancer agent.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoxazoles; Cadherins; Carrier Proteins; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fluorouracil; HT29 Cells; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Microfilament Proteins; Multiprotein Complexes; Protein Kinase Inhibitors; Pyrimidines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2015 |
Orexin A-mediated AKT signaling in the dentate gyrus contributes to the acquisition, expression and reinstatement of morphine-induced conditioned place preference.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Benzoxazoles; Choice Behavior; Conditioning, Psychological; Dentate Gyrus; Disease Models, Animal; Hypothalamic Area, Lateral; Male; Morphine; Naphthyridines; Opioid-Related Disorders; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Urea | 2016 |
Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep.
Topics: Animals; Appetitive Behavior; Benzoxazoles; Brain; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Hypnotics and Sedatives; Male; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Rats, Sprague-Dawley; Reinforcement Schedule; Self Administration; Sleep; Urea | 2015 |
[18F]FEBMP: Positron Emission Tomography Imaging of TSPO in a Model of Neuroinflammation in Rats, and in vitro Autoradiograms of the Human Brain.
Topics: Acetanilides; Animals; Benzoxazoles; Brain; Brain Ischemia; Carrier Proteins; Disease Models, Animal; Fluorine Radioisotopes; Humans; Inflammation; Male; Mice; Neuroimaging; Positron-Emission Tomography; Radiography; Rats, Sprague-Dawley; Receptors, GABA; Receptors, GABA-A | 2015 |
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice.
Topics: Adenosine Triphosphate; Allosteric Site; Animals; Anti-HIV Agents; Benzoxazoles; Catalytic Domain; CD4-Positive T-Lymphocytes; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; HIV Infections; HIV-1; Humans; Interleukin-2; Leukocytes, Mononuclear; Lymphocytes; Mice; NF-kappa B; Pyrimidines; TOR Serine-Threonine Kinases; Transcription, Genetic | 2015 |
Salviaolate Protects Rat Brain from Ischemia-Reperfusion Injury through Inhibition of NADPH Oxidase.
Topics: Animals; Antioxidants; Benzofurans; Benzoxazoles; Brain; Brain Ischemia; Cells, Cultured; China; Cinnamates; Depsides; Disease Models, Animal; Drugs, Chinese Herbal; Male; NADPH Oxidases; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosmarinic Acid; Salvia miltiorrhiza; Triazoles | 2015 |
Upregulation of orexin receptor in paraventricular nucleus promotes sympathetic outflow in obese Zucker rats.
Topics: Action Potentials; Animals; Benzoxazoles; Blood Pressure; Central Nervous System Agents; Disease Models, Animal; Male; Naphthyridines; Neuroanatomical Tract-Tracing Techniques; Neurons; Obesity; Orexin Receptors; Orexins; Paraventricular Hypothalamic Nucleus; Rats, Zucker; Spinal Cord; Sympathetic Nervous System; Tissue Culture Techniques; Up-Regulation; Urea | 2015 |
Synthesis and Preliminary Evaluation of N-Oxide Derivatives for the Prevention of Atherothrombotic Events.
Topics: Animals; Benzoxazoles; Collagen; Disease Models, Animal; Epinephrine; Humans; Mice; Molecular Docking Simulation; Molecular Structure; Oxadiazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism | 2015 |
Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference.
Topics: Animals; Arousal; Behavior, Animal; Benzoxazoles; Blood Glucose; Brain; Conditioning, Psychological; Disease Models, Animal; Feeding Behavior; Hypoglycemia; Male; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Rats, Sprague-Dawley; Reward; Sertraline; Signal Transduction; Time Factors; Urea | 2016 |
Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoxazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Models, Animal; Humans; Immunohistochemistry; Lung Neoplasms; Mice; Phenformin; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins p21(ras); Pyrimidines; Stress, Physiological | 2015 |
Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis.
Topics: Acute Disease; Animals; Benzoxazoles; Chromatography, Liquid; Crystallography, X-Ray; Disease Models, Animal; HEK293 Cells; Hepatocytes; Humans; In Vitro Techniques; Kidney; Kynurenine 3-Monooxygenase; Lung; Mice; Mice, Knockout; Multiple Organ Failure; Oxazolidinones; Pancreas; Pancreatitis; Propionates; Rats; RNA, Messenger; Tandem Mass Spectrometry; Tryptophan | 2016 |
The role of trigeminal nucleus caudalis orexin 1 receptors in orofacial pain transmission and in orofacial pain-induced learning and memory impairment in rats.
Topics: Animals; Benzoxazoles; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Facial Pain; Learning Disabilities; Male; Maze Learning; Memory Disorders; Motor Activity; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Psychomotor Performance; Rats; Rats, Wistar; Reaction Time; Sensory System Agents; Spatial Learning; Trigeminal Nuclei; Urea | 2016 |
Role of orexin-A in experimental autoimmune encephalomyelitis.
Topics: Animals; Attention; Avoidance Learning; Benzoxazoles; Body Weight; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Exploratory Behavior; Female; Matrix Metalloproteinase 9; Maze Learning; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Myelin-Oligodendrocyte Glycoprotein; Naphthyridines; Nitric Oxide Synthase Type II; Orexin Receptor Antagonists; Orexins; Peptide Fragments; Severity of Illness Index; Spinal Cord; Time Factors; Urea | 2016 |
mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease.
Topics: Anemia; Anemia, Sickle Cell; Animals; Benzoxazoles; Disease Models, Animal; Erythrocytes; Hematocrit; Hemoglobins; Mice; Pyrimidines; Sirolimus; Splenomegaly; TOR Serine-Threonine Kinases | 2016 |
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis.
Topics: Amyloid Neuropathies, Familial; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoxazoles; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Gene Expression; Humans; Liver; Macaca fascicularis; Male; Mice; Mice, Transgenic; Prealbumin; RNA Interference; RNA, Messenger; RNA, Small Interfering | 2016 |
Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling.
Topics: Animals; Benzoxazoles; Cyclic AMP; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Forkhead Transcription Factors; Gene Expression Regulation; Homeodomain Proteins; Immunosuppressive Agents; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Regeneration; Neural Conduction; Neurofilament Proteins; Piperazines; Sciatic Neuropathy; Signal Transduction | 2016 |
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.
Topics: Animals; Benzoxazoles; Disease Models, Animal; Dopamine; Enteric Nervous System; Eosinophils; Gastrointestinal Diseases; Gastrointestinal Motility; Glial Fibrillary Acidic Protein; Indoles; Male; Mast Cells; Neurodegenerative Diseases; Oxidopamine; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Sympatholytics; Tyrosine 3-Monooxygenase | 2016 |
Functional interaction between orexin-1 and CB1 receptors in the periaqueductal gray matter during antinociception induced by chemical stimulation of the lateral hypothalamus in rats.
Topics: Animals; Benzoxazoles; Carbachol; Disease Models, Animal; Hypothalamic Area, Lateral; Male; Microinjections; Naphthyridines; Orexin Receptors; Orexins; Pain; Pain Measurement; Periaqueductal Gray; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Stimulation, Chemical; Urea | 2016 |
The role of trigeminal nucleus caudalis orexin 1 receptor in orofacial pain-induced anxiety in rat.
Topics: Animals; Anxiety; Benzoxazoles; Capsaicin; Disease Models, Animal; Exploratory Behavior; Facial Pain; Formaldehyde; Male; Maze Learning; Microinjections; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Pain Measurement; Rats; Rats, Wistar; Time Factors; Trigeminal Nuclei; Urea | 2016 |
Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.
Topics: Alcohol Drinking; Alcohol-Related Disorders; Animals; Animals, Outbred Strains; Benzoxazoles; Central Nervous System Depressants; Conditioning, Operant; Cues; Disease Models, Animal; Drug-Seeking Behavior; Ethanol; Male; Motivation; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Rats, Sprague-Dawley; Self Administration; Urea | 2017 |
Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats.
Topics: Animals; Benzoxazoles; Disease Models, Animal; Glutamic Acid; Locus Coeruleus; Male; Microinjections; Morphine; Naphthyridines; Orexin Receptor Antagonists; Orexins; Rats, Wistar; Substance Withdrawal Syndrome; Urea | 2017 |
Hepatocyte autotaxin expression promotes liver fibrosis and cancer.
Topics: Animals; Benzoxazoles; Biopsy, Needle; Carcinoma, Hepatocellular; Case-Control Studies; Cells, Cultured; Chronic Disease; Disease Models, Animal; Disease Progression; Gene Deletion; Hepatocytes; Humans; Immunohistochemistry; Liver Cirrhosis; Liver Neoplasms; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Phosphoric Diester Hydrolases; Piperazines | 2017 |
Novel benzoxazole derivatives DCPAB and HPAB attenuate Th1 cell-mediated inflammation through T-bet suppression.
Topics: Adoptive Transfer; Animals; Anti-Inflammatory Agents; Antibodies; Benzoxazoles; CD3 Complex; Colitis; Disease Models, Animal; Gene Expression Regulation; Interferon-gamma; Lymph Nodes; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Primary Cell Culture; Promoter Regions, Genetic; Spleen; T-Box Domain Proteins; Th1 Cells | 2017 |
Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis.
Topics: Animals; Benzoxazoles; Biomarkers; Biopsy; Butyrates; Disease Models, Animal; Female; Gene Expression Regulation; Lipid Metabolism; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; PPAR alpha; Rodentia; Severity of Illness Index; Uncoupling Protein 3 | 2017 |
Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation.
Topics: Adamantane; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Benzamides; Benzoxazoles; Calcium; Disease Models, Animal; Humans; Inflammation; Inhibitory Concentration 50; Pain; Purinergic P2 Receptor Antagonists; Quinolinium Compounds; Rats; Receptors, Purinergic P2X7 | 2008 |
Synthesis of 2-substituted-6-(4H-1,2,4-triazol-4-yl)benzo[d]oxazoles as potential anticonvulsant agents.
Topics: Animals; Anticonvulsants; Behavior, Animal; Benzoxazoles; Carbamazepine; Disease Models, Animal; Electric Stimulation; Female; Injections, Intraperitoneal; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Structure; Motor Activity; Pentylenetetrazole; Rotarod Performance Test; Seizures | 2009 |
Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system.
Topics: Alcohol Drinking; Analysis of Variance; Animals; Benzoxazoles; Central Nervous System Depressants; Conditioning, Classical; Cues; Disease Models, Animal; Ethanol; Hypothalamus; Male; Naphthyridines; Neuropeptides; Orexin Receptors; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Self Administration; Substance-Related Disorders; Urea | 2009 |
Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
Topics: Animals; Antiparkinson Agents; Benzoxazoles; Cocaine; Corpus Striatum; Disease Models, Animal; Docosahexaenoic Acids; Dopamine; Dopamine Uptake Inhibitors; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Female; Iodine Isotopes; Levodopa; Macaca fascicularis; Naltrexone; Neuropeptides; Ovariectomy; Parkinsonian Disorders; Piperidines; Protein Precursors; RNA, Messenger; Sulfonamides; Tachykinins; Thiazoles; Time Factors | 2010 |
Orexin/hypocretin is necessary for context-driven cocaine-seeking.
Topics: Analysis of Variance; Animals; Benzoxazoles; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Disease Models, Animal; Extinction, Psychological; Intracellular Signaling Peptides and Proteins; Male; Naphthyridines; Neuropeptides; Orexin Receptors; Orexins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reinforcement, Psychology; Self Administration; Time Factors; Urea | 2010 |
Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing.
Topics: Animals; Benzoxazoles; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Freund's Adjuvant; Ganglia, Spinal; Hyperalgesia; Imidazoles; Inflammation; Male; Microglia; Neurons, Afferent; Neuropeptides; Nociceptors; Organ Culture Techniques; Pain Measurement; Peptides; Peripheral Nervous System Diseases; Proteomics; Pyridines; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, trkA; Receptors, Purinergic P2; Receptors, Purinergic P2X3; Signal Transduction; Spinal Cord Injuries; Time Factors; Up-Regulation | 2009 |
Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys.
Topics: Animals; Antiparkinson Agents; Benzoxazoles; Cabergoline; Corpus Striatum; Disease Models, Animal; Drug Interactions; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Ergolines; Female; Glycogen Synthase Kinase 3; Levodopa; Macaca fascicularis; Oncogene Protein v-akt; Parkinsonian Disorders; Phosphorylation; Piperidines; Serine; Signal Transduction; Statistics as Topic | 2010 |
Ca(2+)-dependent reduction of glutamate aspartate transporter GLAST expression in astrocytes by P2X(7) receptor-mediated phosphoinositide 3-kinase signaling.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Aspartic Acid; Astrocytes; Benzoxazoles; Calcium; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Excitatory Amino Acid Transporter 1; Female; Gene Expression Regulation; Glutamic Acid; Humans; Injections, Spinal; Neurons; Phosphatidylinositol 3-Kinases; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X7; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Spinal Cord Injuries; Transfection | 2010 |
Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia.
Topics: Animals; Benzoxazoles; Cerebral Cortex; Conditioning, Operant; Corticosterone; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drinking; Drug Synergism; Haloperidol; Intracellular Signaling Peptides and Proteins; Male; Naphthyridines; Neuropeptides; Orexins; Psychotic Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Urea | 2010 |
Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets.
Topics: Analysis of Variance; Animals; Antiparasitic Agents; Benzoxazoles; Callithrix; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesias; Female; Locomotion; Male; Motor Activity; MPTP Poisoning; Piperazines; Time Factors | 2010 |
The partial dopamine agonist pardoprunox (SLV308) administered in combination with l-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Area Under Curve; Benzoxazoles; Callithrix; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Motor Activity; Movement Disorders; Piperazines; Statistics, Nonparametric; Time Factors | 2010 |
Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal.
Topics: Animals; Avoidance Learning; Benzoxazoles; Conditioning, Classical; Disease Models, Animal; Intracellular Signaling Peptides and Proteins; Male; Microinjections; Midline Thalamic Nuclei; Morphine; Naloxone; Naphthyridines; Neuropeptides; Orexin Receptors; Orexins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Substance Withdrawal Syndrome; Urea | 2011 |
Hcrtr1 and 2 signaling differentially regulates depression-like behaviors.
Topics: Animals; Anxiety; Benzoxazoles; Choice Behavior; Depression; Disease Models, Animal; Immobility Response, Tonic; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Naphthyridines; Orexin Receptors; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Signal Transduction; Swimming; Urea | 2011 |
Antagonism of orexin 1 receptors eliminates motor hyperactivity and improves homing response acquisition in juvenile rats exposed to alcohol during early postnatal period.
Topics: Animals; Animals, Newborn; Benzoxazoles; Disease Models, Animal; Drug Interactions; Ethanol; Homing Behavior; Hyperkinesis; Male; Naphthyridines; Orexin Receptors; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Urea | 2011 |
Benzoxaboroles: a new class of potential drugs for human African trypanosomiasis.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Benzamides; Benzoxazoles; Boron Compounds; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Male; Mice; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosomiasis, African | 2011 |
Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
Topics: Analysis of Variance; Animals; Animals, Newborn; Arachidonic Acids; Benzoxazines; Benzoxazoles; Biphenyl Compounds; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Disease Models, Animal; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Estrenes; gamma-Aminobutyric Acid; Glycerides; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Intracellular Signaling Peptides and Proteins; Lactones; Male; Morpholines; Naphthalenes; Naphthyridines; Neural Inhibition; Neural Pathways; Neuropeptides; Orexin Receptors; Orexins; Orlistat; Pain; Pain Measurement; Patch-Clamp Techniques; Periaqueductal Gray; Piperidines; Pyrazoles; Pyrrolidinones; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Urea | 2011 |
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.
Topics: Adenosine Triphosphate; Animals; Benzoxazoles; Calcium; Carbenoxolone; Cells, Cultured; Chronic Pain; Cohort Studies; Connexins; Disease Models, Animal; Enzyme Inhibitors; Female; Genetic Linkage; Genome-Wide Association Study; Genotype; Histidine; Humans; Hyperalgesia; Macrophages; Male; Mastectomy; Mice; Mice, Inbred Strains; Mutation; Nerve Tissue Proteins; Osteoarthritis; Pain Measurement; Pain Threshold; Peptides; Polymorphism, Single Nucleotide; Quinolinium Compounds; Receptors, Purinergic P2X7; Retrospective Studies; Species Specificity; Time Factors; Transfection | 2012 |
Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia.
Topics: Animals; Anxiety; Benzoxazoles; Bradycardia; Disease Models, Animal; Hypercapnia; Hypertension; Intracellular Signaling Peptides and Proteins; Male; Naphthyridines; Neurons; Neuropeptides; Orexin Receptors; Orexins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Respiration; Urea | 2012 |
The differential effects of OX1R and OX2R selective antagonists on morphine conditioned place preference in naïve versus morphine-dependent mice.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Antigens, Surface; Benzoxazoles; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Isoquinolines; Male; Mice; Morphine; Morphine Dependence; Naphthyridines; Orexin Receptors; Pyridines; Receptors, Cell Surface; Receptors, Neuropeptide; Urea | 2013 |
Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia.
Topics: Adult; Animals; Benzoxazoles; Bone Marrow; Cell Proliferation; Colony-Forming Units Assay; Disease Models, Animal; Female; Flow Cytometry; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; TOR Serine-Threonine Kinases; Treatment Outcome; Tumor Cells, Cultured | 2013 |
Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis.
Topics: Animals; Benzoxazoles; Cell Growth Processes; Cystadenoma; Disease Models, Animal; Immunohistochemistry; Kidney Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mice; Multiprotein Complexes; Phosphorylation; Pyrimidines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tuberous Sclerosis | 2013 |
Therapeutic potential of a specific chymase inhibitor in atopic dermatitis.
Topics: Acetamides; Administration, Oral; Animals; Antipruritics; Behavior, Animal; Benzoxazoles; Chymases; Dermatitis, Atopic; Disease Models, Animal; Dose-Response Relationship, Drug; Immunoglobulin E; Mice; Pruritus; Rats; Serine Endopeptidases; Serine Proteinase Inhibitors | 2002 |
Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats.
Topics: Aging; Animals; Benzoxazoles; Blood Gas Analysis; Blood Pressure; Carrier Proteins; Cerebral Cortex; Chromatography, High Pressure Liquid; Disease Models, Animal; Heart Rate; Hemodynamics; Hemoglobins; In Vitro Techniques; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Male; Naphthyridines; Neuropeptides; Norepinephrine; Orexins; Potassium Chloride; Rats; Time Factors; Urea | 2003 |
Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys.
Topics: Animals; Benzoxazoles; Corpus Striatum; Disease Models, Animal; Drug Interactions; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Levodopa; Macaca fascicularis; Parkinson Disease; Piperidines; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2004 |
Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Autoradiography; Benzoxazoles; Binding, Competitive; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Humans; Injections, Intravenous; Macromolecular Substances; Mice; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Contribution of orexin in hypercapnic chemoreflex: evidence from genetic and pharmacological disruption and supplementation studies in mice.
Topics: Animals; Benzoxazoles; Carbon Dioxide; Chemoreceptor Cells; Disease Models, Animal; Electroencephalography; Electromyography; Hypercapnia; Hypothalamus; Hypoxia; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Naphthyridines; Neuropeptides; Orexin Receptors; Orexins; Pulmonary Ventilation; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reflex; Time Factors; Urea; Wakefulness | 2007 |
Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-dopa-induced dyskinesias in MPTP parkinsonian monkeys.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Benzoxazoles; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Convulsants; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Flunitrazepam; GABA Modulators; Isotopes; Levodopa; Macaca fascicularis; Ovariectomy; Parkinsonian Disorders; Piperidines; Protein Binding; Radiography; Receptors, GABA; Substantia Nigra | 2008 |
In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas' disease.
Topics: Acute Disease; Animals; Antibodies, Protozoan; Benzoxazoles; Chagas Disease; Disease Models, Animal; Female; Mice; Parasitemia; Treatment Outcome; Trypanosoma cruzi | 2008 |
Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice.
Topics: Adipose Tissue, Brown; Animals; Benzoxazoles; Body Composition; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Eating; Energy Metabolism; Female; Insulin; Mice; Mice, Inbred Strains; Naphthyridines; Obesity; Orexin Receptors; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; RNA, Messenger; Urea | 2002 |